You are here: Home » News-CM » Companies » News
Business Standard

Zydus receives final approval from the USFDA for Acyclovir Ointment

Capital Market 

Zydus Cadila has received the final approval from the USFDA to market Acyclovir Ointment USP (US RLD Zovirax), 5%. It will be manufactured at the group's Topical manufacturing facility at Ahmedabad.

Acyclovir is an antiviral drug which stops the growth of certain viruses.

This medication is used to treat the first outbreak of genital herpes infection. It is also used to treat non-life threatening herpes infections of the skin and around the mouth (cold sores) in people with a weakened immune system.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, March 19 2019. 16:37 IST